Taysha Gene Therapies Analyst Ratings
Taysha Gene Therapies (TSHA) Gets a Buy From Piper Sandler
Taysha Gene Therapies Analyst Ratings
Taysha Gene Therapies Analyst Ratings
Taysha Gene Therapies Analyst Ratings
Taysha Gene Therapies Analyst Ratings
Cantor Fitzgerald Reaffirms Their Buy Rating on Taysha Gene Therapies (TSHA)
Buy Rating Affirmed: Taysha Gene Therapies Poised for Breakthrough on Pediatric Data and FDA Support
Analysts Offer Insights on Healthcare Companies: Sutro Biopharma (STRO), Athira Pharma (ATHA) and Taysha Gene Therapies (TSHA)
Analysts Are Bullish on These Healthcare Stocks: Taysha Gene Therapies (TSHA), Biogen (BIIB)
Truist Financial Reaffirms Their Buy Rating on Taysha Gene Therapies (TSHA)
Taysha Gene Therapies (TSHA) Gets a Buy From Cantor Fitzgerald
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Acadia Healthcare (ACHC) and Taysha Gene Therapies (TSHA)
Taysha Gene Therapies Analyst Ratings
Taysha Gene Therapies Upgraded at Jefferies on Rett Syndrome Asset
Taysha Gene Therapies Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA) and Zimmer Biomet Holdings (ZBH)
Taysha Gene Therapies Analyst Ratings
Taysha Gene Therapies Analyst Ratings
Taysha Gene Therapies Analyst Ratings